Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?

Huiyu Xu, Xianhua Zhang, R. Yang, G. Feng, Li Yang, Rong Li
{"title":"Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?","authors":"Huiyu Xu, Xianhua Zhang, R. Yang, G. Feng, Li Yang, Rong Li","doi":"10.59717/j.xinn-med.2023.100010","DOIUrl":null,"url":null,"abstract":"These authors contributed equally *Correspondence: roseli001@bjmu.edu.cn(R.L.); lilianyangli@163.com(L.Y.) Received: April 12, 2023; Accepted: May 20, 2023; Published Online: May 26, 2023; https://doi.org/10.59717/j.xinn-med.2023.100010 © 2023 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Citation: Xu H., Zhang X., Yang R., et al., (2023). Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?. The Innovation Medicine 1(1), 100010. Dear Editor,","PeriodicalId":423184,"journal":{"name":"The Innovation Medicine","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Innovation Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59717/j.xinn-med.2023.100010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

These authors contributed equally *Correspondence: roseli001@bjmu.edu.cn(R.L.); lilianyangli@163.com(L.Y.) Received: April 12, 2023; Accepted: May 20, 2023; Published Online: May 26, 2023; https://doi.org/10.59717/j.xinn-med.2023.100010 © 2023 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Citation: Xu H., Zhang X., Yang R., et al., (2023). Can androgens be replaced by AMH in initial screening of Polycystic Ovary Syndrome?. The Innovation Medicine 1(1), 100010. Dear Editor,
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在多囊卵巢综合征的初始筛查中,AMH可以替代雄激素吗?
这些作者的贡献相同*通信:roseli001@bjmu.edu.cn(R.L.);lilianyangli@163.com (L.Y.)收稿日期:2023年4月12日;录用日期:2023年5月20日;在线出版:2023年5月26日;https://doi.org/10.59717/j.xinn-med.2023.100010©2023作者。这是一篇基于CC BY-NC-ND许可(http://creativecommons.org/licenses/by-nc-nd/4.0/)的开放获取文章。引用本文:徐辉,张旭,杨锐,等(2023)。在多囊卵巢综合征的初始筛查中,AMH能否替代雄激素?创新医学1(1),100010。亲爱的编辑,
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A new perspective in the research of antibody drug conjugate CDK4/6 inhibition: What��s happening beyond CDK4/6 inhibition may also matter Young adults' blood selenium and lung function in Shandong Province, China: A prospective cohort study Advancing the battle against Alzheimer's Disease: a focus on targeting tau pathology by antisense oligonucleotide Basiliximab is the potential solution for severe liver chronic GVHD: A prospective pilot study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1